“…Since the development of new metallodrugs for cancer treatment based on tertiary phosphines/aminophosphines [27,28,29,30,31,32] the interest for these types of ligands has reemerged. Both PTA and its derivatives have been applied in the synthesis of biologically active Pt(II/IV) [33,34,35,36,37], Au(I) [38,39,40], Ru(II) [41,42,43,44,45,46,47], Ag(I) [48,49,50,51] and Cu(I) [52,53,54,55] metal complexes. Indeed, phosphines can provide beneficial properties such as better stability in biological media (thus reducing undesired side reactions) and moldable affinity for polar and apolar environments in the cell (modifying the compounds transport across the membrane and their accumulation).…”